Paid Clinical Trials in Clermont, FL
As of August 2026, 42 paid clinical trials are recruiting in Clermont, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Clermont offers studies at sites including Clermont Oncology Center for conditions such as Crohn's Disease, Non-Small Cell Lung Cancer, Alzheimer's Disease, Alzheimers Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Clermont
Trials by drug in Clermont
Filter results
41 clinical trials
Study of DONQ52 in Active Celiac Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Patient Retrospective Outcomes (PRO)
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
GEMINI-NSCLC: NSCLC Biomarker Study
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
AngelMed Guardian® System PMA Post Approval Study
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Visugromab in Cachexia International Trial
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Observational Study Protocol: LIVER-R
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Top Research Study Locations in Clermont
Researchers run research studies in Clermont, FL at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Clermont Oncology Center | Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Advanced Non-squamous Non-small-cell Lung Cancer | 13 |
| K2 Medical Research - Winter Garden | Psychosis Associated With Alzheimer's Disease, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| Novum Research | Crohn's Disease, Colitis Ulcerative | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| K2 Medical Research-Winter Garden | Alzheimers Disease | 2 |
| Orlando Health Neuroscience Institute | Chronic Pain, Chronic Leg Pain, Chronic Low-back Pain | 2 |
| Novum Research, LLC | Ulcerative Colitis, Ulcerative Colitis Chronic, Crohn's Disease | 2 |
| Clermont Ambulatory Surgical Center | Acute Coronary Syndrome | 1 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 1 |
| K2 - Winter Garden | Alzheimer's Disease, Alzheimer's Disease, Early Onset, Memory Disorders | 1 |
| K2 Medical Research - Clermont | Alzheimer's Disease | 1 |
| K2 Medical Research WINTER GARDEN | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| K2 Medical Research Winter Garden LLC | Lewy Body Dementia Psychosis | 1 |
| Novum Clinical Research | Celiac Disease | 1 |
| Novum Research, LLC | Ulcerative Colitis | 1 |
| Orlando Health Neuroscience Institute, Inc | Pain | 1 |
| South Lake Hosp | Lumbar Spinal Stenosis | 1 |
| South Lake Pain Institute | AD, Alzheimer Disease, Cognitive Impairment | 1 |
| South Lake Pain Institute, Inc | Pain | 1 |
| Zai Lab | Small-cell Lung Cancer | 1 |
Active & Upcoming Studies in Clermont (2026)
Recruiting trials in Clermont grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (12 active studies)
- Visugromab in Cachexia International Trial · Phase 2, Phase 3 · CatalYm GmbH
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
Neurology & pain (4 active studies)
- Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control · Boston Scientific Corporation
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) · Cognito Therapeutics, Inc.
Diabetes & metabolic (3 active studies)
Cardiovascular (1 active study)
- AngelMed Guardian® System PMA Post Approval Study · Angel Medical Systems
Common conditions studied in Clermont
- Crohn's Disease (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Alzheimer's Disease (2 active studies)
- Alzheimers Disease (2 active studies)
- Chronic Pain (2 active studies)
- Diffuse Large B-Cell Lymphoma (2 active studies)
Leading research sponsors in Clermont
- Merck Sharp & Dohme LLC
- Sanofi
- Boston Scientific Corporation
- Eli Lilly and Company
- 89bio, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Clermont?
There are approximately 42 recruiting clinical trials in Clermont, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Clermont pay participants?
Most recruiting trials in Clermont compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Clermont?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Clermont?
The most common conditions under active study in Clermont include Crohn's Disease (3), Non-Small Cell Lung Cancer (3), Alzheimer's Disease (2), Alzheimers Disease (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Clermont?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Clermont on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Clermont?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Clermont?
Recruiting research sites in Clermont include Clermont Oncology Center, K2 Medical Research - Winter Garden, Novum Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Clermont right now?
The largest active categories in Clermont are Cancer & tumors (12), Neurology & pain (4), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.